0775.HK
0775.HK
KYG2176J1058
CKLIFE SCIENCES
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 20/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.4x).

Beta (Market Relation)
0.45x
Defensive
Volatility (5Y p.a.)
60.2% p.a.
5-Year Horizon
Max Drawdown (5Y)
-74.6%
5-Year Horizon
Sharpe Ratio
-0.15
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -49.5%
3 Years 48.8% -56.3% -0.21 -7.6%
5 Years 60.2% -74.6% -0.15 -6.3%
10 Years 71.6% -74.6% -0.08 -2.9%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (60.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -74.6% in the extended horizon.
ende